Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC)

2021 ◽  
pp. 105234
Author(s):  
Rahul Pawara ◽  
Iqrar Ahmad ◽  
Deepika Nayak ◽  
Shivani Wagh ◽  
Avinash Wadkar ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Double Mutant ◽  
Small Cell ◽  
Small Cell Lung ◽  
Mutant Egfr

scholarly journals Targeting the Oncogenic MUC1-C Protein Inhibits Mutant EGFR-Mediated Signaling and Survival in Non–Small Cell Lung Cancer Cells

2014 ◽  
Vol 20 (21) ◽  
pp. 5423-5434 ◽  
Author(s):  
Akriti Kharbanda ◽  
Hasan Rajabi ◽  
Caining Jin ◽  
Jeremy Tchaicha ◽  
Eiki Kikuchi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
C Protein ◽  
Mutant Egfr

scholarly journals A case treated with nivolumab after small cell lung cancer transformation of mutant EGFR non-small cell lung cancer

2016 ◽  
Vol 27 (12) ◽  
pp. 2300-2301 ◽  
Author(s):  
S. Nishikawa ◽  
Y. Tambo ◽  
H. Ninomiya ◽  
T. Oguri ◽  
Y. Kawashima ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Mutant Egfr

scholarly journals Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR

2018 ◽  
Vol 39 (5) ◽  
pp. 719-727 ◽  
Author(s):  
Hidejiro Torigoe ◽  
Hiromasa Yamamoto ◽  
Masakiyo Sakaguchi ◽  
Chen Youyi ◽  
Kei Namba ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Suppressive Effect ◽  
Small Cell ◽  
Negative Regulator ◽  
Small Cell Lung ◽  
Tumor Suppressive Effect ◽  
Mutant Egfr

scholarly journals HSP70 Causes EGFR-Tkis Resistance in a Mutant EGFR Expressed Non-Small-Cell Lung Cancer

2012 ◽  
Vol 23 ◽  
pp. xi116
Author(s):  
T. Ohmori ◽  
T. Yamaoka ◽  
Y. Ichihashi ◽  
T. Hirose ◽  
N. Saijo
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tkis ◽  
Mutant Egfr

scholarly journals Overexpression of mutant EGFR protein indicates a better survival benefit from EGFR-TKI therapy in non-small cell lung cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (33) ◽  
pp. 52862-52869 ◽  
Author(s):  
Yun Ling ◽  
Xin Yang ◽  
Wenbin Li ◽  
Zhuo Li ◽  
Lin Yang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Survival Benefit ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tki ◽  
Mutant Egfr
Sign in / Sign up

Export Citation Format

Share Document